Project Details
Description
To determine the effectiveness of RORγ inhibitors in prevention of relapse and amelioration of clinical disease in PLP139-151-induced R-EAE in SJL mice.
| Status | Finished |
|---|---|
| Effective start/end date | 3/25/15 → 3/25/17 |
Funding
- Eli Lilly and Company (Agmt 3/25/15)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.